Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.

Future oncology (London, England) - 1 Nov 2021

Salati Massimiliano, Venetis Konstantinos, Fassan Matteo, Malapelle Umberto, Pagni Fabio, Sajjadi Elham, Fusco Nicola, Ghidini Michele

Abstract excerpt

Gastroesophageal adenocarcinoma (GEA) is a global health issue with a high fatality-to-case ratio and a 5-year overall survival that has only slightly improved. High-throughput molecular profiling has uncovered a profound complexity and heterogeneity in GEA biology, which limits considerably the treatment advances. Liquid biopsy with circulating tumor (ct)DNA analysis could elucidate GEA molecular heterogeneity...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Decision-Making

Share to Esophageal Neoplasms

Share to Liquid Biopsy

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Stomach Neoplasms

Source

Identifiers

PMID: 34406032
DOI: 10.2217/fon-2021-0228

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.PMID 34406032Read ↗

Clinical applications and perspectives of circulating tumor DNA in gastric cancerSemantic proximity Read ↗

Circulating Tumor DNA in Gastric and Gastroesophageal Junction CancerSemantic proximity Read ↗

A Review of Circulating Tumor DNA in the Diagnosis and Monitoring of Esophageal Cancer.Semantic proximity Read ↗

Development of circulating tumour DNA analysis for gastrointestinal cancersSemantic proximity Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)Semantic proximity Read ↗

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.Semantic proximity Read ↗

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.Semantic proximity Read ↗

The current state of molecular profiling in gastrointestinal malignancies.Semantic proximity Read ↗

Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker studySemantic proximity Read ↗

Genomics and Targeted Therapies in Gastroesophageal AdenocarcinomaSemantic proximity Read ↗

Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.